Neuronetics is trading 5.3% up now at $3.38 after investors continued digesting its August 11 earnings beat.
- Second-quarter revenue reached $41.6 million, while adjusted EBITDA turned positive at $0.3 million.
- Management raised gross-margin guidance while narrowing revenue guidance.
- BTIG subsequently raised its price target to $6; broader risk-on sentiment may also be supporting the move.